Oxytocin selectively moderates negative cognitive appraisals in high trait anxious males

Psychoneuroendocrinology

Volumn 37, Issue 12, 2012, Pages 2022-2031

  Alvares, Gail A ^a   Chen, Nigel T M ^a   Balleine, Bernard W ^a   Hickie, Ian B ^a   Guastella, Adam J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Anxiety; Attention; Cognition; Eye gaze; Individual differences; Oxytocin; Social anxiety; Stress

Indexed keywords

NOSE SPRAY; OXYTOCIN; PLACEBO;

ADULT; ANXIETY; ARTICLE; COGNITION; CONTROLLED STUDY; GAZE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PERCEPTION; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SELF EVALUATION; SOCIAL STRESS; SPEECH; TASK PERFORMANCE;

ADMINISTRATION, INTRANASAL; ADULT; AFFECT; ANXIETY; COGNITION; DIAGNOSTIC SELF EVALUATION; DOUBLE-BLIND METHOD; EYE MOVEMENTS; HUMANS; MALE; OXYTOCIN; PERSONALITY INVENTORY; PHOTIC STIMULATION; PSYCHOMOTOR PERFORMANCE; VISUAL PERCEPTION;

EID: 84869884031     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2012.04.018     Document Type: Article

References (59)

1. Bartz J.A., Zaki J., Bolger N., Hollander E., Ludwig N.N., Koller R., Ochsner K.N. Oxytocin selectively improves empathic accuracy. Psychol. Sci. 2010, 21:1426-1428.
2. Bartz J.A., Zaki J., Bolger N., Ochsner K.N. Social effects of oxytocin in humans: context and person matter. Trends Cogn. Sci. 2011, 15:301-309.
3. Bartz J.A., Zaki J., Ochsner K.N., Bolger N., Kolevzon A., Ludwig N., Lydon J.E. Effects of oxytocin on recollections of maternal care and closeness. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:21371-21375.
4. Baumgartner T., Heinrichs M., Vonlanthen A., Fischbacher U., Fehr E. Oxytocin shapes the neural circuitry of trust and trust adaptation in humans. Neuron 2008, 58:639-650.
5. Beck A.T., Clark D.A. An information processing model of anxiety: automatic and strategic processes. Behav. Res. Ther. 1997, 35:49-58.
6. Bishop S.J. Neurocognitive mechanisms of anxiety: an integrative account. Trends Cogn. Sci. 2007, 11:307-316.
7. Brandes M., Bienvenu O.J. Personality and anxiety disorders. Curr. Psychiatry Rep. 2006, 8:263-269.
8. Breiter H.C., Etcoff N.L., Whalen P.J., Kennedy W.A., Rauch S.L., Buckner R.L., et al. Response and habituation of the human amygdala during visual processing of facial expression. Neuron 1996, 17:875-887.
9. Calvo M.G., Avero P. Time course of attentional bias to emotional scenes in anxiety: gaze direction and duration. Cogn. Emot. 2005, 19:433-451.
10. Cisler J.M., Koster E.H.W. Mechanisms of attentional biases towards threat in anxiety disorders: an integrative review. Clin. Psychol. Rev. 2010, 30:203-216.
11. de Oliveira D.C.G., Zuardi A.W., Graeff F.G., Queiroz R.H.C., Crippa J.A.S. Anxiolytic-like effect of oxytocin in the simulated public speaking test. J. Psychopharmacol. 2012, 26:497-504.
12. Domes G., Heinrichs M., Glascher J., Buchel C., Braus D.F., Herpertz S.C. Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biol. Psychiatry 2007, 62:1187-1190.
13. Domes G., Heinrichs M., Michel A., Berger C., Herpertz S. Oxytocin improves "mind-reading" in humans. Biol. Psychiatry 2007, 61:731-733.
14. Domes G., Lischke A., Berger C., Grossmann A., Hauenstein K., Heinrichs M., Herpertz S.C. Effects of intranasal oxytocin on emotional face processing in women. Psychoneuroendocrinology 2010, 35:83-93.
15. Ellenbogen M.A., Linnen A.M., Grumet R., Cardoso C., Joober R. The acute effects of intranasal oxytocin on automatic and effortful attentional shifting to emotional faces. Psychophysiology 2012, 49:128-137.
16. Ferguson J.N., Aldag J.M., Insel T.R., Young L.J. Oxytocin in the medial amygdala is essential for social recognition in the mouse. J. Neurosci. 2001, 21:8278-8285.
17. Gamer M., Zurowski B., Büchel C. Different amygdala subregions mediate valence-related and attentional effects of oxytocin in humans. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:9400-9405.
18. Goldin P.R., Manber-Ball T., Werner K., Heimberg R., Gross J.J. Neural mechanisms of cognitive reappraisal of negative self-beliefs in social anxiety disorder. Biol. Psychiatry 2009, 66:1091-1099.
19. Guastella A.J., Einfeld S.L., Gray K.M., Rinehart N.J., Tonge B.J., Lambert T.J., Hickie I.B. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biol. Psychiatry 2010, 67:692-694.
20. Guastella A.J., Howard A.L., Dadds M.R., Mitchell P., Carson D.S. A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder. Psychoneuroendocrinology 2009, 34:917-923.
21. Guastella A.J., MacLeod C. A critical review of the influence of oxytocin nasal spray on social cognition in humans: evidence and future directions. Horm. Behav. 2012, 61:410-418.
22. Guastella A.J., Mitchell P.B., Dadds M.R. Oxytocin increases gaze to the eye region of human faces. Biol. Psychiatry 2008, 63:3-5.
23. Guastella A.J., Mitchell P.B., Mathews F. Oxytocin enhances the encoding of positive social memories in humans. Biol. Psychiatry 2008, 64:256-258.
24. Heinrichs M., Baumgartner T., Kirschbaum C., Ehlert U. Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol. Psychiatry 2003, 54:1389-1398.
25. Heinrichs N., Hofmann S.G. Information processing in social phobia: a critical review. Clin. Psychol. Rev. 2001, 21:751-770.
26. Kirsch P., Esslinger C., Chen Q., Mier D., Lis S., Siddhanti S., et al. Oxytocin modulates neural circuitry for social cognition and fear in humans. J. Neurosci. 2005, 25:11489-11493.
27. Kirschbaum C., Pirke K., Hellhammer D. The 'Trier Social Stress Test'-a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 1993, 28:76-81.
28. Kosfeld M., Heinrichs M., Zak P.J., Fischbacher U., Fehr E. Oxytocin increases trust in humans. Nature 2005, 435:673-676.
29. Labuschagne I., Phan K.L., Wood A., Angstadt M., Chua P., Heinrichs M., et al. Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder. Neuropsychopharmacology 2010, 35:2403-2413.
30. Landgraf R., Neumann I.D. Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Front. Neuroendocrinol. 2004, 25:150-176.
31. Lee P.R., Brady D.L., Shapiro R.A., Dorsa D.M., Koenig J.I. Prenatal stress generates deficits in rat social behavior: reversal by oxytocin. Brain Res. 2007, 1156:152-167.
32. Lischke A., Berger C., Prehn K., Heinrichs M., Herpertz S.C., Domes G. Intranasal oxytocin enhances emotion recognition from dynamic facial expressions and leaves eye-gaze unaffected. Psychoneuroendocrinology 2012, 37:475-481.
33. Lovibond P.F., Lovibond S.H. Manual for the Depression Anxiety Stress Scale 1995, Psychology Foundation, Sydney.
34. Lukas M., Toth I., Reber S.O., Slattery D.A., Veenema A.H., Neumann I.D. The neuropeptide oxytocin facilitates pro-social behavior and prevents social avoidance in rats and mice. Neuropsychopharmacology 2011, 36:2159-2168.
35. Marsh A.A., Yu H.H., Pine D.S., Blair R.J. Oxytocin improves specific recognition of positive facial expressions. Psychopharmacology (Berl.) 2010, 209:225-232.
36. McGregor I.S., Callaghan P.D., Hunt G.E. From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?. Br. J. Pharmacol. 2009, 154:358-368.
37. McNair D., Lorr M., Droppleman L. Profile of Mood States (POMS) 1989, Educational and Industrial Testing Service, San Diego, CA.
38. Meyer-Lindenberg A., Domes G., Kirsch P., Heinrichs M. Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat. Rev. Neurosci. 2011, 12:524-538.
39. Mitchell M.D., Haynes P.J., Anderson A.B.M., Turnbull A.C. Plasma oxytocin concentrations during the menstrual cycle. Eur. J. Obstet. Gynecol. Reprod. Biol. 1981, 12:195-200.
40. Neumann I.D. Involvement of the brain oxytocin system in stress coping: interactions with the hypothalamo-pituitary-adrenal axis. Prog. Brain Res. 2002, 139:147-162.
41. Norman G.J., Cacioppo J.T., Morris J.S., Karelina K., Malarkey W.B., DeVries A.C., Berntson G.G. Selective influences of oxytocin on the evaluative processing of social stimuli. J. Psychopharmacol. 2011, 25(10):1313-1319.
42. Petrovic P., Kalisch R., Singer T., Dolan R.J. Oxytocina attenuates affective evaluations of conditioned faces and amygdala activity. J. Neurosci. 2008, 28:6607-6615.
43. Pflugshaupt T., Mosimann U.P., Wartburg R.v., Schmitt W., Nyffeler T., Müri R.M. Hypervigilance-avoidance pattern in spider phobia. J. Anxiety Disord. 2005, 19:105-116.
44. Quirin M., Kuhl J., Düsing R. Oxytocin buffers cortisol responses to stress in individuals with impaired emotion regulation abilities. Psychoneuroendocrinology 2011, 36:898-904.
45. Rapee R.M., Abbott M.J. Modelling relationships between cognitive variables during and following public speaking in participants with social phobia. Behav. Res. Ther. 2007, 45:2977-2989.
46. Rapee R.M., Heimberg R.G. A cognitive-behavioral model of anxiety in social phobia Behav. Res. Ther. 1997, 35:741-756.
47. Rapee R.M., Lim L. Discrepancy between self and observer ratings of performance in social phobics. J. Abnorm. Psychol. 1992, 101:728-731.
48. Ross H.E., Young L.J. Oxytocin and the neural mechanisms regulating social cognition and affiliative behavior. Front. Neuroendocrinol. 2009, 30:534-547.
49. Salonia A., Nappi R., Pontillo M., Daverio R., Smeraldi A., Briganti A., et al. Menstrual cycle-related changes in plasma oxytocin are relevant to normal sexual function in healthy women. Horm. Behav. 2005, 47:164-169.
50. Schneier F.R., Johnson J., Hornig C.D., Liebowitz M.R., Weissman M.M. Social phobia: comorbidity and morbidity in an epidemiologic sample. Arch. Gen. Psychiatry 1992, 49:282-288.
51. Schulze L., Lischke A., Greif J., Herpertz S., Heinrichs M., Domes G. Oxytocin increases recognition of masked emotional faces. Psychoneuroendocrinology 2011, 36:1378-1382.
52. Slattery D.A., Neumann I.D. Chronic icv oxytocin attenuates the pathological high anxiety state of selectively bred Wistar rats. Neuropharmacology 2010, 58:56-61.
53. Spielberger C.D., Gorsuch R.L., Lushene R., Vagg P.R., Jacobs G.A. Manual for the State-Trait Anxiety Inventory 1983, Consulting Psychologists Press, Palo Alto, CA.
54. The MathWorks Inc. MATLAB, version 7.11 2010, The MathWorks Inc., Natick, MA.
55. Theodoridou A., Rowe A.C., Penton-Voak I.S., Rogers P.J. Oxytocin and social perception: oxytocin increases perceived facial trustworthiness and attractiveness. Horm. Behav. 2009, 56:128-132.
56. Tobii Technology User Manual: Tobii X60 and X120 Eye Trackers 2008, Tobii Technology AB, Danderyd, Sweden.
57. Veljaca K., Rapee R. Detection of negative and positive audience behaviours by socially anxious subjects. Behav. Res. Ther. 1998, 36:311-321.
58. Viviani D., Stoop R. Opposite effects of oxytocin and vasopressin on the emotional expression of the fear response. Prog. Brain Res. 2008, 170:207-218.
59. Windle R.J., Shanks N., Lightman S.L., Ingram C.D. Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology 1997, 138:2829-2834.